ALMR · Alamar Biosciences, Inc.
Price & Indicators
The closing range uses available history since Apr 17, 2026; less than a full year is stored.
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Gross margin | 60% | the second quarter of 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ALMR
this stock
Alamar Biosciences, Inc.
|
$2.27B | — | — | — | 3.0% |
|
ABT
Abbott Laboratories
|
$203.22B | -7.3% | +5.7% | 32.7 | 1.2% |
|
SYK
Stryker Corp
|
$125.74B | -5.9% | +11.2% | 34.0 | 1.8% |
|
MDT
Medtronic plc
|
$119.56B | -5.1% | +8.4% | 25.0 | 1.1% |
|
BSX
Boston Scientific Corp
|
$72.26B | -47.7% | +12.5% | 20.2 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ALMR | +0.2% | +33.6% | — | +30.2% | — |
| SPY | -0.2% | +3.4% | +11.8% | +2.5% | +12.3% |
| vs SPY | +0.4% | +30.3% | — | +27.7% | — |